Liotta LA - Search Results

1

Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.

Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC. Davidson B, et al. Among authors: liotta la. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):791-9. doi: 10.1158/1078-0432.CCR-05-2516. Clin Cancer Res. 2006. PMID: 16467090

2

The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.

Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC. Jones MB, et al. Among authors: liotta la. Clin Cancer Res. 2003 Jan;9(1):44-51. Clin Cancer Res. 2003. PMID: 12538450

3

Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.

Gulmann C, Espina V, Petricoin E 3rd, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL. Gulmann C, et al. Among authors: liotta la. Clin Cancer Res. 2005 Aug 15;11(16):5847-55. doi: 10.1158/1078-0432.CCR-05-0637. Clin Cancer Res. 2005. PMID: 16115925

4

Proteomic analysis for early detection of ovarian cancer: a realistic approach?

Stevens EV, Liotta LA, Kohn EC. Stevens EV, et al. Among authors: liotta la. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:133-9. doi: 10.1111/j.1525-1438.2003.13358.x. Int J Gynecol Cancer. 2003. PMID: 14656269 Review.

5

Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.

Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC, Petricoin EF 3rd. Jones MB, et al. Among authors: liotta la. Proteomics. 2002 Jan;2(1):76-84. Proteomics. 2002. PMID: 11788994

6

General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.

Liotta LA, Petricoin EF 3rd, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC. Liotta LA, et al. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S25-8; discussion S37-42. doi: 10.1006/gyno.2002.6679. Gynecol Oncol. 2003. PMID: 12586081 Review. No abstract available.

7

Biomarkers of ovarian tumours.

Rapkiewicz AV, Espina V, Petricoin EF 3rd, Liotta LA. Rapkiewicz AV, et al. Among authors: liotta la. Eur J Cancer. 2004 Nov;40(17):2604-12. doi: 10.1016/j.ejca.2004.05.021. Eur J Cancer. 2004. PMID: 15541961 Review.

8

Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays.

Cowherd SM, Espina VA, Petricoin EF 3rd, Liotta LA. Cowherd SM, et al. Among authors: liotta la. Clin Breast Cancer. 2004 Dec;5(5):385-92. doi: 10.3816/cbc.2004.n.046. Clin Breast Cancer. 2004. PMID: 15585078 Review.

9

Pathology of the future: molecular profiling for targeted therapy.

Espina V, Geho D, Mehta AI, Petricoin EF 3rd, Liotta LA, Rosenblatt KP. Espina V, et al. Among authors: liotta la. Cancer Invest. 2005;23(1):36-46. Cancer Invest. 2005. PMID: 15779867 Review.

10

Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis.

Winters ME, Mehta AI, Petricoin EF 3rd, Kohn EC, Liotta LA. Winters ME, et al. Among authors: liotta la. Cancer Res. 2005 May 1;65(9):3853-60. doi: 10.1158/0008-5472.CAN-04-1989. Cancer Res. 2005. PMID: 15867384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

689 results

Search Page